Alnylam Signs CRADA With US Army to Develop RNAi-Based Antivirals

Apr 13, 2006

NEW YORK, April 13 (GenomeWeb News) - Alnylam Pharmaceuticals and the United States Army Medical Research Institute of Infectious Diseases plan to co-develop RNAi therapeutics targeting viruses, Alnylam said yesterday.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

Not Always an Answer

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

CRISPR Acceptance or Not?

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

This Week in Science

In Science this week: research regulation and reporting requirement reform, and more.

Building Up Numbers

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.

Main menu